Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy

[News]

Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment.

More... (http://www.news-medical.net/news/20120611/Distinct-cancer-signatures-may-help-predict-response-to-estrogen-lowering-therapy.aspx)